Korean researchers have proposed a new treatment strategy that can increase the effectiveness of the genetic rare disease 'Duchenne Muscular Dystrophy (DMD)'. The research team noted that ...

T cell-based immunotherapies, including CAR-T cell therapies, have significantly advanced treatment options for lymphomas such as diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL).

Roles of EZH2 in cancer. Genes & Diseases publishes rigorously peer-reviewed and high quality original articles and authoritative reviews that focus on the molecular bases of human diseases.

Using an unbiased approach, this important study discovered a role of Ezh2 in the differentiation of granule neuron precursors, the cell of origin for Shh group of medulloblastoma. Furthermore, the ...

TAZVERIK ® is a registered trademark of Epizyme Inc., an Ipsen company.

HUTCHMED has received conditional approval from the National Medical Products Administration (NMPA) in China for TAZVERIK® (tazemetostat), marking it as the first EZH2 inhibitor approved in the ...